Structure-based design of a protein-protein interaction inhibitor, ABT-263, for the treatment of cancer

被引：0
|
作者：
Wendt, Michael D. [1 ]
机构：
[1] Abbott Labs, Global Pharmaceut R&D, Canc Res, Abbott Pk, IL 60064 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2009年 / 238卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
246-MEDI
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Structure-based drug design and molecular dynamics studies of an allosteric modulator targeting the protein-protein interaction site of PDK1
    Natesan, Vennila Kailasam
    Pitchaimuthu, Elango Kuppannagounder
    JOURNAL OF MOLECULAR MODELING, 2024, 30 (02)
  • [42] Structure-based design of highly potent small-molecule inhibitors of DCN1-UBC12 protein-protein interaction
    Zhou, Haibin
    Lu, Jianfeng
    Liu, Liu
    Bernard, Denzil
    Stuckey, Jeanne
    Sun, Yi
    Wang, Shaomeng
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [43] Structure-based prediction of protein-protein and protein-ligand interactions on a genomic scale
    Garzon, Jose
    Hwang, Howook
    Dey, Fabian
    Murray, Diana
    Petrey, Donald
    Honig, Barry
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [44] Design of Protein-Protein Interaction Inhibitors Based on Protein Epitope Mimetics
    Robinson, John A.
    CHEMBIOCHEM, 2009, 10 (06) : 971 - 973
  • [45] Interdiction at a protein-protein interface: Structure-based design and optimization of spirocyclic Mcl-1 inhibitors
    Li, Kexue
    Brown, Sean
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [46] PROTEIN STRUCTURE-BASED DRUG DESIGN
    WHITTLE, PJ
    BLUNDELL, TL
    ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 1994, 23 : 349 - 375
  • [47] Contributions of protein structure-based drug design to cancer chemotherapy
    Jackson, RC
    SEMINARS IN ONCOLOGY, 1997, 24 (02) : 164 - 172
  • [48] On the structure of protein-protein interaction networks
    Thomas, A
    Cannings, R
    Monk, NAM
    Cannings, C
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2003, 31 : 1491 - 1496
  • [49] The Bcl-2/xL inhibitor ABT-263 increases the stability of Mcl-1 mRNA and protein in hepatocellular carcinoma cells
    Wang, Bin
    Ni, Zhenhong
    Dai, Xufang
    Qin, Liyan
    Li, Xinzhe
    Xu, Liang
    Lian, Jiqin
    He, Fengtian
    MOLECULAR CANCER, 2014, 13
  • [50] Combining protein interaction potentials with water analysis in structure-based design
    Cheeseright, Tim
    Mackey, Mark
    Tedesco, Giovanna
    Tomasio, Susana
    Tosco, Paolo
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
12345